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Clinical Case Report and Review
ABSTRACT
Spindle cell squamous cell carcinoma (SpSCC) is a rare biphasic malignant neoplasm, uncommonly affecting the oral 
cavity. The SpSCC diagnosis is difficult, especially when it exhibits inconspicuous morphology, inadequate tissue sampling, 
or association with an exuberant inflammatory reaction. Post-radiotherapy recurrent SpSCC occurring at the same site 
of conventional SCC is a rare phenomenon. A 59-year-old man was complained of “painful injury on the tongue” 
with 20 days of duration. He reported smoking and alcohol consumption. Medical history revealed conventional SCC 
on the tongue treated with surgery and radiotherapy 10 years ago. Intraoral examination showed a polypoid lesion 
with ulcerated areas, measuring 3 cm in diameter, on the tongue and floor of the mouth, at the same site of previous 
conventional SCC. The microscopical analysis showed small foci of carcinomatous component admixed with an exuberant 
inflammatory reaction. Immunohistochemistry highlighted the sarcomatoid component. Both malignant components 
were positive for EMA, CD138, p40 (deltaNp63), p63, and p53. Moreover, CK AE1/AE3 evidenced the carcinomatous 
component, whereas vimentin stained the sarcomatoid component. The Ki-67 was >10%. The current case emphasizes 
the importance of immunohistochemistry in the differential diagnosis of SpSCC from mimics and documents a rare 
complication of Ionizing Radiation. 
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INTRODUCTION
Squamous cell carcinoma (SCC) accounts for 
about 90% of the oral and oropharyngeal cancers. Oral 
cavity SCC (OSCC) is the most common malignancy 
of the head and neck region.1 The tobacco smoking 
and alcohol consumption are the main etiological 
factors of the OSCC.2 In the last decades, human 
papillomavirus (HPV) has emerged as a major etiologic 
factor for oropharyngeal SCC (OPSCC) and on the 
lips, the ultraviolet radiation plays a central role in 
the carcinogenesis.2-4 The OSCC includes several 
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histopathological variants, including verrucous, 
basaloid, adenoid, spindle cell, adenosquamous and 
undifferentiated. The understanding of its microscopic 
peculiarities is fundamental for correct diagnosis and 
consequently adequate treatment.5
Spindle cell SCC (SpSCC) of the head and neck 
region is a rare, biphasic neoplasm with aggressive 
behavior.6 The main sites of occurrence are the 
upper aerodigestive tract, larynx, and hypopharynx; 
nevertheless, in the oral cavity, the occurrence is 
rare, accounting for less than 1% of all SCCs.7 The 
clinical presentation of SpSCC usually vary from 
exophytic, polypoid mass with an ulcerated surface 
to an infiltrative ulcer and the histopathological 
characteristics exhibit a dysplastic epithelium with foci 
of infiltration and connective tissue stroma containing 
numerous spindle-shaped cells, many of them round 
to oval in shape with eosinophilic and vacuolated 
cytoplasm, nuclear hyperchromatism and atypical 
mitoses.8,9 Interestingly, SpSCC after radiotherapy 
treatment in some conventional SCC patients have 
been reported.10 Thus, a detailed clinicopathological 
analysis of similar cases is encouraged better to 
understand their pathogenesis, treatment, and 
prognosis.11
CASE REPORT
A 59-year-old male Caucasian patient was 
referred with the main complaint of “wound in 
the tongue” is lasting 20 days. On the clinical 
examination, a painful, exophytic, polypoid lesion 
was observed with approximately 3 cm in diameter 
associated with ulcerative areas on the floor of 
the mouth with extension to the adjacent tongue 
(Figure 1).
On the extraoral examination, nothing of note was 
identified. According to the patient, the lesion started 
30 days ago, and it increased in size. The medical 
history was remarkable for a previous diagnosis of well-
differentiated SCC in this same region 10 years ago 
(Figure 2), clinically presented as an ulcerated lesion, 
being the patient staged as T3N0M0.
The t reatment cons is ted of  surgery and 
conventional external beam radiotherapy with 70 Gy 
in 35 sessions. An incisional biopsy was performed, 
and the histopathological analysis revealed a biphasic 
tumor consisting of a carcinomatous component 
evidenced by dysplastic and infiltrative epithelium, 
focal formation of keratin pearls and an intense 
inflammatory cell infiltrate permeating a sarcomatoid 
component (Figure 3).
T h e  i m m u n o h i s t o c h e m i c a l  a n a l y s i s 
(Figure 4 and 5) showed positivity for cytokeratin 
A E 1 / A E 3  h i g h l i g h t i n g  t h e  c a r c i n o m a t o u s 
component, while that vimentin strongly stained 
the sarcomatoid component. Moreover, EMA, 
CD138, p40 (deltaNp63), p63, and p53 highlighted 
both carcinomatous and sarcomatoid components. 
Of them, only the EMA expression was weak and 
focal in the sarcomatoid component. S100 protein 
was negative. The Ki-67 labeling index was >10%. 
The final diagnosis was SpSCC, and the patient 
Figure 1. Clinical features of recurrent SpSCC after 
radiotherapy at the same site of previous conventional 
well-differentiated SCC. Polypoid nodular lesion on 
the floor of the mouth and tongue, surrounded by 
erythematous areas.
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Figure 2. Histopathological features of oral SCC: neoplastic epithelium with conventional pattern (Original 
magnification, A, x10; B, x20) (H&E stain).
Figure 3. Histopathological features of SpSCC: Biphasic tumor consisting of infiltrating neoplastic epithelium in 
close relationship to spindle cells (H&E, A, x10; B, x20). Dysplastic epithelium and overt pleomorphism of the spindle 
cells in the sarcomatoid component (H&E, C, x20; D, x20).
was referred to the oncologist. The patient was 
submitted to tumor resection and complementary 
radiotherapy with a total dose of 70 Gy even as 
the first radiotherapy 10 years ago. After 1-year of 
follow-up, no sign of recurrence or alteration was 
observed.
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DISCUSSION
SpSCCs of the head and neck region are rare 
variants of SCC, representing less than 3% of all 
head and neck SCCs. The most frequently involved 
sites in the oral cavity are the lower lip, tongue, and 
gingiva.6 Microscopically, SpSCC is characterized by the 
presence of two distinct morphological components, 
carcinomatous and sarcomatoid or spindle cell 
proliferation, with both components of epithelial 
origin.8 Post-radiotherapy SpSCC is a rare complication. 
Interestingly, the current case is the third SpSCC 
originated after surgical resection and radiotherapy 
of conventional SCC, with both tumors being 
diagnosed in the same location, at the head and neck 
region. Taking into consideration that radiotherapy 
has beneficial effects in the SCC treatment, the 
development of SCC after radiotherapy is uncommon 
and deserves special attention to better understand its 
pathogenesis, treatment, and prognosis.12
A systematic review conducted by Brown et al.13 
in OSCC shows no difference in local recurrence 
between patients who underwent surgical treatment 
alone and surgical treatment with postoperative 
radiotherapy. On the other hand, overall survival 
seems to be relatively lesser in those patients receiving 
surgical treatment with postoperative radiotherapy.13 
Therefore, these results indicate the need for more 
randomized clinical trials and possible changes in 
cancer treatment protocols, aiming to improve the 
quality of life of these patients. Additionally, according 
Figure 4. Immunohistochemical analysis of the SpSCC on consecutive serial tissue sections. A – Positive reaction 
for CK AE1/AE3 in the carcinomatous component; B – Vimentin highlighted the sarcomatoid component; C – EMA 
expression was weak and detected scarce sarcomatoid cells (arrows); D – CD138 evidenced both carcinomatous and 
sarcomatoid components (A and B x10, C x40 and D x20).
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to Cahan et al.14 study, some tumor types may originate 
due to exposure to different types of radiation. It is 
not possible to determine from histopathological 
examination whether a tumor occurring in a radiation 
field has been induced by radiation.14,15 However there 
are in the scientific literature many report cases of 
malignant neoplasms, either SCCs or sarcomas, which 
appeared after treatment with radiotherapy.7,10,11,16,17
The cause of tumor development in the radiation 
field may be explained for dose-response effects 
and the tumor type.18 For example, the Colleman 
study19 noted that the induction of sarcomas requires 
higher doses, especially in thyroid and breast, since 
lower doses may induce leukemia. For SCC, scientific 
researches demonstrating the exact amount of dose 
for carcinogenic induction were not found; however, 
for SpSCC cases arising after radiotherapy treatment 
from conventional SCC, the amount of radiation used 
appears to be sufficient to induce carcinogenesis.19 A 
total radiation dose may vary between 50-70 Gy for 
SCC in the head and neck region.20
According to Baker et al.21 study, fibrosis, and 
vascular changes induced by radiotherapy may be 
responsible for the development of secondary malignant 
neoplasms. The radiation can induce chromosome 
aberrations such as asymmetrical rearrangements that 
may be observed at the first mitosis in tumor cells, and 
normal-cells.22 Radiation may also induce high levels 
of micronuclei standing acentric fragments or whole 
chromosome loss at anaphase.23 Thus, further studies 
of the tumor microenvironment and cell pathways can 
clarify the possible mechanisms involved in cases of 
recurrence and neoplasms induced by radiation.
Figure 5. Immunohistochemical analysis of the SpSCC on consecutive serial tissue sections. A – Positive reaction for 
p40 (deltaNp63) in both sarcomatoid and carcinomatous components; as well as in B – positivity for p63; C – The 
sarcomatoid component showing positive nuclear staining for p53; and D – Ki-67 (>10%) (A and B x20, C and D x10).
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The nonneoplastic effects of radiation on mucosal 
tissues are dependent on the type of tissue irradiated. 
The most typical alterations occur in the lamina 
propria, submucosa, and deep soft tissues of the 
mouth, pharynx, larynx, and genitalia, which reveal 
fibrosis and lack or paucity of inflammatory exudate, 
followed by fibrinous exudate, atypical fibroblasts, 
and necrosis. Noteworthy, the radiation-induced 
mesenchymal stromal cell alterations can mimic a 
malignant neoplasm, either carcinoma or sarcoma.24-26 
Thus, strict clinicopathological correlation, supported 
by immunohistochemistry, is necessary to achieve a 
correct diagnosis.
We also conducted a literature review considering 
recurrence in cases of SpSCC in the head and neck 
region and other information such as demographic 
data, primary tumor, location, treatment, and time 
of recurrence.7,9,10,27-34 In most cases, the location of 
recurrence and the initial site of involvement were the 
same. The initial treatment most commonly used was a 
combination of surgery and radiotherapy, and surgery 
alone was often associated with recurrence. The time 
of recurrence ranged from 2 months to 11 years. 
Table 1 shows the clinicopathological features of 
primary conventional SCC and recurrence as SpSCC, 
and Table 2 shows the clinicopathological features of 
primary SpSCC and recurrence as SpSCC. It is worth 
noting that twenty cases of recurrent SpSCC were not 
included in the tables due to lack of clinicopathological 
data.35-37 According to our literature review, there are 
forty-four cases of recurrent SpSCC in the head and 
neck region, of which only nine cases originated from 
conventional SCC. The present study relates to the 
tenth case.
The histopathological diagnosis of SpSCC in 
the head and neck region is often difficult due to 
embryologically and anatomically complex area, small 
sample sizes of biopsy, and often inflammatory cell 
infiltrate admixed with malignant cells. Moreover, 
because SpSCC may present four histopathological 
patterns, including monomorphic, pleomorphic, 
biphasic, and myxoid, the diagnosis is challenging. In 
addition, the microscopic distinction of SpSCC from 
other malignant mesenchymal spindle cell neoplasms 
may require aid from immunohistochemistry.38 The 
correct understanding of these histopathological 
aspects is fundamental to achieve the correct diagnosis. 
In the present study, the sarcomatoid component of 
the SpSCC was obscured by an intense inflammatory 
cell infiltrate.
However, after immunohistochemical analysis, the 
spindle cells revealed positivity for EMA, CD138, p40 
(deltaNp63), p63 and p53, with significant proliferative 
index (Ki-67, >10%). Our findings are in agreement 
with other reported SpSCC cases.39,40














Takata et al.27 50/M Gingiva S+Rad SpSCC Oropharynx SCC S+Chm 18
83/F Buccal mucosa Rad SpSCC Buccal mucosa SCC S+Rad+Chm 5
71/F Tongue Rad SpSCC Gingiva SCC S 2
76/M Gingiva/FoM S+Rad SpSCC Tongue SCC S 11
Minami et al.28 58/F Esophagus Rad SpSCC Oropharynx SCC S 11
Kinra et al.10 56/M Larynx S+Rad SpSCC Oropharynx SCC S 3
Oktay et al.7 55/F Tongue S+Rad SpSCC Tongue SCC S+Rad 8
Manickam et al.29 62/M Larynx S+Rad SpSCC Larynx SCC S 3
Okuyama et al.30 62/F Tongue Surg SpSCC Tongue SCC S 4
Index case 49/M Tongue S+Rad SpSCC FoM/Tongue SCC S+Rad 10
Legend: Chm: chemotherapy; F: female; FoM: floor of the mouth; M: male; S: surgery; SCC: squamous cell carcinoma; 
Rad: radiotherapy; SpSCC: spindle cell squamous cell carcinoma; Tx: treatment; y: years.
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N/A N/A Tongue Rad SpSCC Tongue SpSCC N/A N/A
N/A N/A Tongue/FoM Rad SpSCC Tongue/FoM SpSCC N/A N/A
N/A N/A Retromolar trigone Rad SpSCC
Retromolar 











Evans31 N/A N/A Lower lip Rad SpSCC Lower lip SpSCC N/A N/A
N/A N/A Buccal mucosa Rad SpSCC
Buccal 
mucosa SpSCC N/A N/A
N/A N/A Buccal mucosa Rad SpSCC
Buccal 
mucosa SpSCC N/A N/A
N/A N/A Lip Rad SpSCC Lip SpSCC N/A N/A
N/A N/A Oropharynx Rad SpSCC Oropharynx SpSCC N/A N/A
76/M N/A Gingiva Chm SpSCC Gingiva SpSCC N/A 0.2
75/F N/A Tongue Rad SpSCC Tongue SpSCC N/A 0.5
49/M N/A FoM S+Chm SpSCC FoM SpSCC N/A 0.2
59/M N/A Tongue S SpSCC Tongue SpSCC N/A 0.5
47/M N/A Oropharynx N/A SpSCC Oropharynx SpSCC N/A 0.5
42/M N/A Oropharynx S+Rad SpSCC Oropharynx SpSCC N/A 4.0
44/M N/A Tongue Surg SpSCC Tongue SpSCC N/A 1.9
42/M N/A Palate S+Rad SpSCC Palate SpSCC N/A 0.7
75/M N/A Buccal mucosa S SpSCC
Buccal 
mucosa SpSCC N/A 1.7
Su et al.32 52/M N/A Buccal mucosa S+Rad SpSCC
Buccal 
mucosa SpSCC N/A 0.6
32/M N/A Tongue S SpSCC Tongue SpSCC N/A 0.2
51/M N/A Buccal mucosa S SpSCC
Buccal 
mucosa SpSCC N/A 2.2
42/M N/A Lip S+Chm SpSCC Lip SpSCC N/A 2.7
59/M N/A Gingiva S SpSCC Gingiva SpSCC N/A 1.1
52/M N/A Tongue S+Rad+Ch SpSCC Tongue SpSCC N/A 1.7
51/M N/A Tongue Surg SpSCC Tongue SpSCC N/A 0.2
46/M N/A Lip S+Rad SpSCC Lip SpSCC N/A 0.7
67/M N/A Buccal mucosa S+Rad SpSCC
Buccal 
mucosa SpCC N/A 0.5
60/M N/A Tongue S+Rad SpSCC Tongue SpSCC Surg 3.7
63/M N/A Tongue S+Rad SpSCC Tongue SpSCC Surg 1.7
Iqbal et al.33 N/A N/A Maxilla S+Rad SpSCC Maxilla SpSCC Surg N/A
N/A N/A Maxilla S+Rad SpSCC Maxilla SpSCC Surg N/A
65/M N/A Hypopharynx S+Rad SpSCC Hypopharynx SpSCC Surg 4.1
63/M N/A Hypopharynx S+Rad SpSCC Hypopharynx SpSCC Surg 1.8
Ohba et al.34 72/F Asian Buccal mucosa S+Rad+Ch SpSCC
Submandibu-




73/F Black Gingiva/Mandible Surg SpSCC
Gingiva/
Mandible SpSCC N/A 0.5
Legend: Chm: chemotherapy; F: female; FoM: floor of the mouth; M: male; N/A: not available; Rad: radiotherapy; S: surgery; 
SpSCC: spindle cell squamous cell carcinoma; Tx: treatment; y: years.
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CONCLUSION
Post-radiotherapy recurrent SpSCC occurring 
at the same site of well-differentiated SCC is a rare 
phenomenon, usually related to poor prognosis. Herein 
we report the fourth case in the head and neck region. 
The histopathological diagnosis can be challenging, 
because, in some cases, the immunohistochemical 
analysis is necessary for the correct diagnosis. Further 
studies assessing recurrent SpSCC after radiotherapy are 
encouraged better to understand their pathogenesis, 
treatment, and prognosis.
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